Caregen Co., Ltd. (KOSDAQ:214370)
32,600
-350 (-1.06%)
Jun 27, 2025, 3:30 PM KST
Caregen Revenue
Caregen had revenue of 21.29B KRW in the quarter ending March 31, 2025, with 4.12% growth. This brings the company's revenue in the last twelve months to 83.43B, up 11.26% year-over-year. In the year 2024, Caregen had annual revenue of 82.59B with 4.26% growth.
Revenue (ttm)
83.43B
Revenue Growth
+11.26%
P/S Ratio
18.16
Revenue / Employee
434.53M
Employees
192
Market Cap
1,514.99B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 82.59B | 3.38B | 4.26% |
Dec 31, 2023 | 79.21B | 10.11B | 14.63% |
Dec 31, 2022 | 69.10B | 10.01B | 16.94% |
Dec 31, 2021 | 59.09B | -1.21B | -2.00% |
Dec 31, 2020 | 60.30B | -4.40B | -6.81% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.10T |
SK hynix | 71.40T |
Samsung Biologics | 4,898.69B |
LG Energy Solution | 25.76T |
Hyundai Motor Company | 178.98T |
Doosan Enerbility | 15.88T |
Hanwha Aerospace | 15.28T |
KB Financial Group | 14.93T |
Caregen News
- 7 months ago - Akums Drugs shares surge 5% after signing Master Sales Agreement with Caregen - Business Upturn
- 7 months ago - Akums Drugs signs Master Sales Agreement with Caregen for Indian Nutraceutical market expansion - Business Upturn